Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-06-02T08:58:33.723Z Has data issue: false hasContentIssue false
  • English
  • Français

Olanzapine or risperidone treatment initiation: SOHO Study Results

Published online by Cambridge University Press:  16 April 2020

E.T. Edgell ,
P. Frewer ,
J.M. Haro ,
D. Novick  and
M. Lothgren
E.T. Edgell
Affiliation:
European Health Outcomes Research, Lilly Research Centre, UK
P. Frewer
Affiliation:
European Health Outcomes Research, Lilly Research Centre, UK
J.M. Haro
Affiliation:
Centre de Salut Mental-Gavè, Sant Joan de Deu-SSM, France
D. Novick
Affiliation:
European Health Outcomes Research, Lilly Research Centre, UK
M. Lothgren
Affiliation:
European Health Outcomes Research, SOHO Advisory Board, UK

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Monday, 6 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 150s
Copyright
Copyright © Elsevier, Paris 2002
Submit a response

Comments

No Comments have been published for this article.